Press Releases

SECOND QUARTER GUIDANCE SUGGESTS ACCELERATING YEAR-OVER-YEAR REVENUE GROWTH EPS OF $0.46 IN THE FIRST QUARTER EXCEEDED THE HIGH END OF GUIDANCE GROSS PROFIT MARGINS IN THE FIRST QUARTER IMPROVED 60 BASIS POINTS YEAR-OVER-YEAR Kforce Inc. (NYSE:KFRC), a solutions firm that specializes in technology and other professional staffing services, today announced results for the first quarter of 2026. Joseph J. Liberatore, President and Chief Executive Officer, said, "We are extremely pleased to have successfully driven results in the first quarter that again exceeded our expectations from both a revenue and profitability perspective. The momentum that we carried into the beginning of the ye

Record Backlog of $8.0 Billion Raising 2026 Revenue Outlook to ~17% YoY Growth Cadence (NASDAQ:CDNS) today announced results for the first quarter of 2026. First Quarter 2026 Financial Results Revenue of $1.474 billion, compared to revenue of $1.242 billion in Q1 2025 GAAP operating margin of 29.3%, compared to 29.1% in Q1 2025 Non-GAAP operating margin of 44.7%, compared to 41.7% in Q1 2025 GAAP diluted net income per share of $1.23, compared to $1.00 in Q1 2025 Non-GAAP diluted net income per share of $1.96, compared to $1.57 in Q1 2025 Quarter-end backlog was $8.0 billion and revenue expected to be recognized in the next 12 months from remaining performance obligati

Southfield, Michigan, April 27, 2026 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (NASDAQ:CACC) (referred to as the "Company", "Credit Acceptance", "we", "our", or "us") announced today that Robert Bourrier has joined the Company as Chief Sales Officer. In this role, Mr. Bourrier will lead and scale Credit Acceptance's national sales organization with a focus on sustained revenue growth, market share expansion, and disciplined financial performance. Partnering closely with the executive leadership team, he will be responsible for translating enterprise strategy into consistent, measurable execution across all markets. His responsibilities include shaping and executing our sales strat

Regulatory feedback recent from April 2026 EU EMA and Australian TGA meetingsRemaining Q2-2026 regulatory meetings include two U.S. FDA meetings and one UK MHRA meeting, in addition to follow-up meetings with EU EMA and Australian TGANew York, New York--(Newsfile Corp. - April 27, 2026) - OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in gene-edited, listeria-based cancer immunotherapies, today announced that it will be hosting a conference call on Thursday April 30, 2026 at 8:30am ET to review the data that supported the recent Patent Cooperation Treaty (PCT) international application for a OST-HER2 pharmacodynamic biomarker1 (the "OST-HER2

Board of Directors Authorize $600 Million Share Repurchase ProgramSAN JOSE, Calif., April 27, 2026 /PRNewswire/ -- Sanmina Corporation ("Sanmina" or the "Company") (NASDAQ:SANM), a leading integrated manufacturing solutions company, today reported financial results for the second quarter ended March 28, 2026 and outlook for its third fiscal quarter ending June 27, 2026. Second Quarter Fiscal 2026 Financial HighlightsRevenue: $4.01 billionGAAP operating margin: 3.9%GAAP diluted EPS: $1.70Non-GAAP(1) operating margin: 6.4%Non-GAAP(1) diluted EPS: $3.16Additional HighlightsCash flow from operations: $399 millionFree cash flow(2): $342 millionShare repurchases: 1.1 million shares for $160 millio

Revenue Growth, Financial Discipline and Strategic Advancements Position the Company Well Bed Bath & Beyond, Inc. (NYSE:BBBY), owner of Bed Bath & Beyond, Overstock, buybuy BABY, and more recently, the Kirkland's and Kirkland's Home brands, as well as a blockchain asset portfolio, today reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights First quarter net revenue was $248 million, representing an increase of 6.9% year-over-year. Net revenue excluding the impact from our exit from Canada (non-GAAP) increased 9.4% year-over-year. Notably this was the first quarter of significant revenue growth in 19 quarters, signaling strong brand awar

Arcturus Therapeutics Holdings Inc. ((the "Company", "Arcturus", NASDAQ:ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced that it will release its financial results for the quarter ended March 31, 2026 after the market close on Thursday, May 7th and will also host a conference call and webcast at 4:30 pm Eastern Time on May 7, 2026. Arcturus Therapeutics First Quarter 2026 Earnings Conference Call Thursday, May 7, 2026, at 4:30 p.m. ET Domestic: 1-800-579-2543 International: 1-785-424-1789 Conference ID: ARCTURUS Webcast: Link About Arcturus Founded in 2013 and based in San Diego, Cal

Janux Therapeutics, Inc. (NASDAQ:JANX) ("Janux"), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today announced that it will discontinue further clinical development of JANX008, its EGFR-targeted Tumor Activated T Cell Engager (TRACTr) program. Following completion of the Phase 1a portion of the study, which included dose escalation and expansion cohorts across multiple solid tumor indications, and an internal review of the data, the Company has determined to prioritize development resources toward other pipeline opportunities. The decision to discontinue JANX008 is program-specific and does not impact the Company's broader TRACTr platfor

Robust monotherapy efficacy in KRAS G12X NSCLC: 62% uORR in 2L+ and 75% uORR in post-ICI/platinum 2/3L at 16-32 mg QD PAD, and 64% uORR in 2L+ at 24-32 mg QD RDE Robust monotherapy efficacy in 2L KRAS G12X PDAC: 40% uORR at 16-32 mg QD PAD, 42% uORR at 24-32 mg QD RDE, and 50% uORR at 32 mg QD Monotherapy generally well-tolerated with mostly low-grade AEs, no DLTs as of DCO, and low rate of dose reductions and no discontinuations due to TRAEs Preliminary data suggest ERAS-0015 may combine safely with standard-of-care doses of panitumumab with no DLTs as of DCO (N=3) and 1/1 uPR in CRC Well-behaved PK, with dose-dependent increase in PK exposure up to MAD of 40 mg QD and no exposure plate

Bed Bath & Beyond, Inc. (NYSE:BBBY) ("Bed Bath & Beyond" or "BBBY") has issued the following letter from Marcus Lemonis, Executive Chairman and Chief Executive Officer of Bed Bath & Beyond: Dear Shareholders, Over the last 2 years, we have fundamentally rebuilt this business. This was not an effort to stabilize short-term performance. It was a deliberate reset of how we operate, with the goal of creating a model that can grow consistently on a lower and more durable cost structure. This required difficult decisions. We simplified the organization, removed layers, consolidated operations, and materially reduced our cost base across headcount, legacy technology, and customer acquisition

WAUWATOSA, Wis., April 27, 2026 (GLOBE NEWSWIRE) -- Waterstone Financial, Inc. (NASDAQ:WSBF) (the "Company") announced that on April 27, 2026, its Board of Directors authorized the repurchase of up to an additional 2,000,000 shares of the Company's outstanding shares of common stock under its existing repurchase program. Prior to this authorization, 148,285 shares remained available to repurchase under the existing program. Combined with the shares authorized today, the total 2,148,285 shares available for repurchase represent approximately 11.9% of the Company's issued and outstanding shares of common stock as of April 27, 2026. The timing of the repurchases will depend on certain factors

AUSTIN, Texas, April 27, 2026 (GLOBE NEWSWIRE) -- Asure Software, Inc. (NASDAQ:ASUR), a provider of payroll and HR solutions for employers and enterprise payroll tax and treasury infrastructure, launched AsureWorks, a done-for-you service in which Asure specialists run payroll and handle day-to-day HR administration on behalf of employer clients. AsureWorks is offered alongside AsureCentral, Asure's payroll and HR software platform powered by Luna AI, giving employers a clear choice in how they operate — do the work themselves on AsureCentral™, or have Asure's team do it for them through AsureWorks. Clients remain the employer of record under either model. Payroll and HR has to be right.

CAMBRIDGE, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that it has commenced an underwritten public offering of $150 million of shares of its common stock. Intellia also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock offered in the public offering. All of the shares in the proposed offering are to be sold by Intellia. Jefferies, Goldman Sachs & Co. LLC and Citigroup are acting as joint book-running managers for the pr

Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - Nicola Mining Inc. (NASDAQ:NICM) (TSXV:NIM) (FSE: HLIA) (the "Company" or "Nicola") is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market making services, including use of its proprietary algorithm, ICP Premium™, in compliance with the policies and guidelines of the TSX Venture Exchange and other applicable legislation. ICP will be paid a monthly fee of C$7,500, plus applicable taxes. The agreement between the Company and ICP was signed with a start date April 27th, 2026 and is for four (4) months (the "Initial Term") and shall be automatically renewed for subsequent

Recognition Highlights Industry Leading, Production Grade AI Transforming Healthcare Operations and Customer Experience WOONSOCKET, R.I., April 27, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) announced it has been named a Gold winner in Enterprise AI and Silver in Customer Experience AI categories at the 2026 Stevie® Awards (American Business Awards®), one of the most prestigious and rigorously judged business awards programs in the United States. The American Business Awards AI categories recognize production‑grade AI systems operating at enterprise scale, evaluated by independent expert judges.

First Quarter Performance Highlights Net Income: Net income for the quarter ended March 31, 2026 totaled $1.9 million or $0.25 per diluted share (including Series A preferred shares). Adjusted (non-GAAP) net income (excluding severance expenses) was $4.0 million or $0.54 per diluted share for the quarter ended March 31, 2026.Net Interest Income: Net interest income was $16.4 million for the quarter ended March 31, 2026, an increase of $0.5 million, or 3.36% from the quarter ended December 31, 2025 and $1.7 million, or 11.85%, from the quarter ended March 31, 2025, representing the highest level since the third quarter of 2022.Net Interest Margin Expansion: The Company's net interest mar

Bed Bath & Beyond, Inc. (NYSE:BBBY) ("Bed Bath & Beyond" or the "Company") today announced that Kyla Robinson will join the Company as Chief Technology Transformation Officer, reporting to President Amy Sullivan. This role is about one thing: Building the intelligence layer that powers our entire business. Over the last two years, the Company has assembled the pieces including retail, home services, financial products, and a growing portfolio of brands. The next phase is connecting those pieces into a single system that learns, adapts, and improves over time. Kyla will lead that effort. "Kyla is a proven technology and product leader who understands how to translate data and AI into

CHATTANOOGA, Tenn., April 27, 2026 (GLOBE NEWSWIRE) -- Astec Industries, Inc. (NASDAQ:ASTE) will host its Investor Day on Wednesday, May 13, 2026. The event will begin at 8 AM ET and will be held virtually, with a live webcast available to investors. Attendees can register and access the presentation with the following link: https://app.webinar.net/prMZLgl1Q7W More information can be found on our microsite: https://astecindustries2026investorday.q4ir.com Chief Executive Officer Jaco van der Merwe and members of Astec's executive leadership team will provide an update on the company's strategic priorities, operational initiatives, and long-term growth framework. Presentations will highli

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Tice P. Brown, a 12% stockholder of Empery Digital Inc. (NASDAQ:EMPD) sent the following letter to the Board of Directors of Empery Digital Inc. April 27th, 2026 To the Shareholders and Board of Directors of Empery Digital Inc. I personally beneficially own 12.1% of Empery Digital Inc.    I write to demand Empery Digital immediately restart maximum daily buybacks. Since February 2026, Empery Digital began selling BTC and buying in stock. Often they bought in nearly 1% of shares outstanding, per day. They trumpeted this in weekly press releases and Twitter videos. Ten business days ago Empery Digital effectively halted this buyback without

Lattice Semiconductor (NASDAQ:LSCC), the low power programmable leader, today announced its exhibition plan for Embedded Vision Summit 2026. During the event, Lattice will present an expert-led track session highlighting its latest FPGA technology, and host a demo-filled booth showcasing edge AI, computer vision, Industrial Human-Machine Interface (HMI), sensor bridging and fusion, and robotics solutions. Joined by a strong lineup of innovation partners, Lattice will demonstrate how its FPGA solutions enable engineers to accelerate physical AI design for Automotive and Industrial applications at the Edge. Who: Lattice Semiconductor What / When: May 11 – 12: Lattice demo showcase (Bo